Catherine Schulte
Stock Analyst at Baird
(3.95)
# 578
Out of 4,944 analysts
131
Total ratings
53.45%
Success rate
9.17%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,292.89 | -4.86% | 10 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $18 → $15 | $12.66 | +18.48% | 13 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $477.41 | +18.77% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $205.72 | +11.32% | 11 | Jul 23, 2025 | |
| A Agilent Technologies | Maintains: Outperform | $159 → $140 | $117.32 | +19.33% | 16 | May 22, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $2.69 | -25.65% | 6 | May 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $41.74 | +72.50% | 14 | May 2, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $48.97 | -12.19% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $52.83 | +28.71% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $19.33 | +96.59% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $27.45 | +20.22% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $285.52 | -24.00% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $159.81 | -87.49% | 1 | Jun 28, 2018 |
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,292.89
Upside: -4.86%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $18 → $15
Current: $12.66
Upside: +18.48%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $477.41
Upside: +18.77%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $205.72
Upside: +11.32%
Agilent Technologies
May 22, 2025
Maintains: Outperform
Price Target: $159 → $140
Current: $117.32
Upside: +19.33%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $2.69
Upside: -25.65%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $41.74
Upside: +72.50%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $48.97
Upside: -12.19%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $52.83
Upside: +28.71%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $19.33
Upside: +96.59%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $27.45
Upside: +20.22%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $285.52
Upside: -24.00%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $159.81
Upside: -87.49%